DBT equipment market seen reaching $13.9 billion by 2033

Persistence Market Research says the digital breast tomosynthesis equipment market will grow from $4.3 billion in 2026 to $13.9 billion by 2033 as hospitals and imaging centers adopt 3D breast imaging for earlier, more accurate cancer detection. North America leads the market now, while Asia Pacific is emerging as one of the fastest-growing regions.

Why it matters: - Digital breast tomosynthesis is gaining ground because 3D breast imaging can improve diagnostic accuracy and help radiologists detect abnormalities earlier than conventional mammography. - The market outlook points to more investment in breast screening equipment as healthcare systems modernize and preventive screening expands. - Breast cancer screening programs and awareness campaigns are directly supporting demand for advanced imaging systems.

What happened: - Persistence Market Research estimates the global digital breast tomosynthesis equipment market will reach $13.9 billion by 2033, up from $4.3 billion in 2026. - The firm projects a 13.9% compound annual growth rate from 2026 to 2033. - The market is being driven by hospitals, diagnostic imaging centers and other providers upgrading breast imaging capabilities. - North America holds the largest market share, while Asia Pacific is among the fastest-growing regions.

The details: - DBT systems create three-dimensional breast images that reduce tissue overlap, lower unnecessary recalls and improve confidence in diagnosis. - Integrated mammography systems with tomosynthesis technology are gaining preference because they combine multiple imaging capabilities in one platform. - Hospitals remain the leading end-user segment because of advanced infrastructure, skilled radiologists and high patient volumes. - Diagnostic imaging centers are expanding as demand rises for specialized breast screening services. - The report points to technological advances in detector sensitivity, image reconstruction software, artificial intelligence and workflow automation as key product improvements. - The report lists key market players as Hologic, GE HealthCare, Siemens Healthineers, FUJIFILM Holdings, Canon Medical Systems, Philips, Planmed, IMS Giotto, Metaltronica and Carestream Health. - The market is segmented by product type, technology, application and end user. - Product categories include standalone DBT systems and integrated mammography systems equipped with tomosynthesis technology. - End users include hospitals, diagnostic imaging centers, specialty clinics and ambulatory healthcare facilities.

Between the lines: - The growth forecast reflects a wider shift toward earlier cancer detection and more sophisticated imaging workflows. - High equipment costs, installation expenses, maintenance needs and staff training requirements still limit adoption, especially for smaller facilities. - Uneven access to advanced breast imaging in developing regions could slow growth where budgets and infrastructure remain constrained. - A shortage of radiologists trained to interpret DBT images remains a practical barrier in some markets. - Europe remains an important market because of government-supported screening initiatives and rising healthcare spending.

What's next: - Healthcare providers are likely to keep replacing older imaging setups with DBT-capable systems as breast cancer screening programs expand. - Emerging markets may attract more equipment makers as healthcare infrastructure improves and public awareness rises. - Vendors are likely to compete on image quality, workflow efficiency and software-driven diagnostic support. - The company offers report customization and a full report for buyers seeking deeper market data. More information